Showing results (341-350 of 362) with videos related to

Sort By:
Pageof 37
Science (New York, N.Y.)|July 7, 1995
In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endotheliumD L Kooyman, G W Byrne, S McClellan, et al.
Tissue Antigens|March 1, 1994
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodiesC J Watson, S P Cobbold, H S Davies, et al.
Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine|September 20, 2007
Respiratory disease markers in porcine bronchoalveolar lavage fluidI Hennig-Pauka, S Bremerich, H Nienhoff, et al.
BMC Genomics|September 21, 2018
Analysis of porcine body size variation using re-sequencing data of miniature and large pigsC Reimer, C-J Rubin, A R Sharifi, et al.
Bone Marrow Transplantation|January 10, 2002
Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantationR Chakraverty, S Robinson, K Peggs, et al.
Bone Marrow Transplantation|January 1, 1993
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletionJ O Cullis, R M Szydlo, N C Cross, et al.
British Journal of Haematology|September 1, 1996
Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remissionA Oakhill, D H Pamphilon, M N Potter, et al.
Bone Marrow Transplantation|May 1, 1996
Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donorsM Hamblin, J C Marsh, M Lawler, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Pageof 37